Indegene Limited raises ₹548.77 crore from 36 anchor investors at the upper price band of ₹452 per equity share - CtrlS Noida Datacenter Turns to Solar for 60% of its Power Requirement, Aims to reduce 94,640 tonnes of CO2 emissions through this move - TBO TEK LIMITED ANNOUNCED IT'S INITIAL PUBLIC OFFERING (IPO) TO OPENS ON 08th May, 2024 Sets Price Band fixed at ₹ 875 to ₹ 920 per equity share of face value of ₹ 1 each - Afternoon Voice Hosts 16th Newsmakers Achievers Award 2024, Recognising Outstanding Contributions Across Various Fields - AADHAR HOUSING FINANCE LIMITED ANNOUNCED ITS INITIAL PUBLIC OFFERING (IPO) OF EQUITY SHARES OPENS ON MAY 8, 2024 Sets Price Band fixed at ₹ 300 to ₹ 315 per equity share of face value of ₹ 10 each - Sankalp Art Fest Presents An Art Exhibition will be held @ Namah Royal Banquet Hall at Borivali (W) in Mumbai - Collaborates with the Akshaya Patra Foundation for Sustainable Growth in India - Kokilaben Hospital launches Arthrex Modular Glenoid System with VIP for Enhanced Shoulder Replacement for the First Time in India - उत्तर मुंबई मतदार संघातील पीयूष गोयल यांचा उमेदवारी अर्ज दाखल, जल्लोषात समर्थन देत भाजप - महायुती कार्यकर्त्यांचे जोरदार शक्तीप्रदर्शन - "Every Picture has a story" An exhibition of Photographs will be displayed by Kabeer Ramesh @ Nitya Artists Centre at Prabhadevi, Mumbai

Quote by Rohitashwa Prasad, Partner, J Sagar Associates on Healthcare & Pharma sector announced by Union Finance Minister Nirmala Sitharaman in the Budget 2021-2022

Mumbai, 01st February 2021 (GNI): Find below quote by Rohitashwa Prasad, Partner, J Sagar Associates on Healthcare & Pharma sector announced by Union Finance Minister Nirmala Sitharaman in the Budget 2021-2022.

“For FY 21 GoI had budgeted Rs. 69,000 crore for healthcare, which was 1.6% of GDP. The budgeted amount for FY 22 shows a significant increase. If this growth were to be extrapolated, the GoI should achieve the target of healthcare spend of 2.5 – 3% of GDP (as envisaged in the National Health Policy 2017) well before its target date.   This is quite promising and clearly illustrates the importance that the GoI is placing on the sector spurred by the Covid pandemic. What is also very commendable is that the GoI has allocated Rs. 35,000 crore for the Covid vaccine as a separate line time. This shows that the GoI has avoided the pitfall of focussing all its resources on tackling communicable diseases at the cost of building healthcare systems generally because of the Covid pandemic, which notwithstanding its materially adverse impact on the health and economy, is an extraordinary event. The GoI has thus avoided the saliency bias which the Economic Survey had warned against.” Rohitashwa Prasad, Partner, J Sagar Associates.ends

Be the first to comment on "Quote by Rohitashwa Prasad, Partner, J Sagar Associates on Healthcare & Pharma sector announced by Union Finance Minister Nirmala Sitharaman in the Budget 2021-2022"

Leave a comment

Your email address will not be published.


*